RT Journal Article
SR Electronic
T1 Norwich COVID-19 Testing Initiative: feasibility project evaluation
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.09.22.20199455
DO 10.1101/2020.09.22.20199455
A1 Gillam, T Berger
A1 Cole, J
A1 Gharbi, K
A1 Hitchcock, M
A1 Edwards, D
A1 Brabbs, T
A1 Lipscombe, J
A1 Davidson, R
A1 Rushworth, S
A1 Steel, N
YR 2020
UL http://medrxiv.org/content/early/2020/09/23/2020.09.22.20199455.abstract
AB Background There is a high prevalence of COVID-19 in university-age students, who are returning to university campuses. There is little evidence regarding the feasibility of universal, asymptomatic testing to control outbreaks in this population. This study aimed to pilot mass COVID-19 testing on a university research park, to assess the feasibility and acceptability of scaling up to all staff and students.Methods This was a cross-sectional feasibility study on a university research park in the East of England. Staff and students (5,625) on the research park were eligible to participate. Polymerase chain reaction (PCR) testing was offered to all participants. Participants were offered 4 swabs, which they self-administered over a two-week period. Outcome measures included: uptake; drop-out rate; positivity rates; participant acceptability measures; laboratory processing measures.Results 798/1053 (76%) of those who registered provided at least one swab and of these, 687 (86%) provided all four. 681/687 (99%) had all negative results. 6 participants had one inconclusive result. There were no positive results. 458/798 (57%) participants responded to a post-testing questionnaire. 446/458 (97.5%) of those who responded agreed that they would be interested in repeat testing in the future.Conclusions Repeated self-testing is feasible and acceptable to a university population.Competing Interest StatementThe authors have declared no competing interest.Funding StatementFunded in part by UK Research and Innovation (UKRI) Biotechnology and Biological Sciences Research Council (BBSRC) Core Capability Grant BBS/E/T/000PR9816.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:UEA ethics committee no. 2019/20-140All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe datasets generated during during the current study are available from the corresponding author on reasonable request.